Colon Cancer Stage IIIb

1 clinical trials · Condition

Record	Firm	Date
Study of Blood Components as Probable Prognostic and Predictive Markers of Response to Treatment in Advanced Colon and Rectal Cancers (NCT02979470)	AC Camargo Cancer Center	2016-09-01

Every clearance here is in the API, with alerts when new ones post.